Mesoblast
MESO
74 hedge funds and large institutions have $75.7M invested in Mesoblast in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 8 closing their positions.
1,343% more call options, than puts
Call options by funds: $42.4M | Put options by funds: $2.94M
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
28% more capital invested
Capital invested by funds: $58.9M → $75.7M (+$16.8M)
20% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 20
9% more funds holding
Funds holding: 68 → 74 (+6)
0.41% more ownership
Funds ownership: 2.86% → 3.27% (+0.41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.72M |
| 2 |
BlackRock
New York
|
+$2.34M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.26M |
| 4 |
Morgan Stanley
New York
|
+$2.26M |
| 5 |
Jane Street
New York
|
+$2.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.97M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.68M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.2M |
| 4 |
RIM
Rockbridge Investment Management
Syracuse,
New York
|
-$792K |
| 5 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
-$578K |
MESO Hedge Fund Activity: Q4 2025 in Review
74 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q4 2025, worth a combined $75.7M — up 28% from $58.9M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new MESO positions and 8 closed out — a net gain of 6 holders — while 24 added to existing stakes and 20 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $2.72M. The largest seller was UBS Group, cutting an estimated $1.97M.
- 74 institutional investors held Mesoblast (MESO) as of Q4 2025, up from 68 in Q3 2025.
- Funds reported $75.7M of Mesoblast stock for Q4 2025, up 28% quarter-over-quarter.
- 14 funds opened new Mesoblast positions in Q4 2025 and 8 closed out, a net change of +6 holders.
- The largest Mesoblast buyer in Q4 2025 was Susquehanna International Group, an estimated $2.72M added.
- The largest Mesoblast seller in Q4 2025 was UBS Group, an estimated $1.97M sold.
Based on aggregated 13F filings for Q4 2025.